CDC6 is a prognostic biomarker and correlated with immune infiltrates in glioma.

Wang F, Zhao F, Zhang L, Xiong L, Mao Q, Liu Y, Qiu X, Wang X, Shui L, Chen X, Ren K, Shui P, Zhang Q, Deng Y, Li W, Xie X, Wu D, Li T, Lang J, Liu L, Chen H, Xu J, Bai S, Li Z, Yue Q, Chen N, Zhou B, Yi C, Wei Y, Fu Y, Luo Y, Gou Q, Liu L, Liu Y, Kang J, Wang J, Jing D, Zhang F, Yang X, Li X, Jiang T, Zhang Z, Zhou Y, Yi J

Open source

DOI: 10.1186/s12943-022-01623-8
Published: 2022 Jul 25
Container: Molecular cancer
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s12943-022-01623-8,
  title = {CDC6 is a prognostic biomarker and correlated with immune infiltrates in glioma.},
  author = {Wang F and Zhao F and Zhang L and Xiong L and Mao Q and Liu Y and Qiu X and Wang X and Shui L and Chen X and Ren K and Shui P and Zhang Q and Deng Y and Li W and Xie X and Wu D and Li T and Lang J and Liu L and Chen H and Xu J and Bai S and Li Z and Yue Q and Chen N and Zhou B and Yi C and Wei Y and Fu Y and Luo Y and Gou Q and Liu L and Liu Y and Kang J and Wang J and Jing D and Zhang F and Yang X and Li X and Jiang T and Zhang Z and Zhou Y and Yi J},
  year = {2022},
  journal = {Molecular cancer},
  doi = {10.1186/s12943-022-01623-8},
  url = {https://doi.org/10.1186/s12943-022-01623-8}
}

RIS

TY  - JOUR
TI  - CDC6 is a prognostic biomarker and correlated with immune infiltrates in glioma.
AU  - Wang F
AU  - Zhao F
AU  - Zhang L
AU  - Xiong L
AU  - Mao Q
AU  - Liu Y
AU  - Qiu X
AU  - Wang X
AU  - Shui L
AU  - Chen X
AU  - Ren K
AU  - Shui P
AU  - Zhang Q
AU  - Deng Y
AU  - Li W
AU  - Xie X
AU  - Wu D
AU  - Li T
AU  - Lang J
AU  - Liu L
AU  - Chen H
AU  - Xu J
AU  - Bai S
AU  - Li Z
AU  - Yue Q
AU  - Chen N
AU  - Zhou B
AU  - Yi C
AU  - Wei Y
AU  - Fu Y
AU  - Luo Y
AU  - Gou Q
AU  - Liu L
AU  - Liu Y
AU  - Kang J
AU  - Wang J
AU  - Jing D
AU  - Zhang F
AU  - Yang X
AU  - Li X
AU  - Jiang T
AU  - Zhang Z
AU  - Zhou Y
AU  - Yi J
PY  - 2022
JO  - Molecular cancer
DO  - 10.1186/s12943-022-01623-8
UR  - https://doi.org/10.1186/s12943-022-01623-8
ER  -

APA

F, W., F, Z., L, Z., L, X., Q, M., Y, L., X, Q., X, W., L, S., X, C., K, R., P, S., Q, Z., Y, D., W, L., X, X., D, W., T, L., J, L., L, L., H, C., J, X., S, B., Z, L., Q, Y., N, C., B, Z., C, Y., Y, W., Y, F., Y, L., Q, G., L, L., Y, L., J, K., J, W., D, J., F, Z., X, Y., X, L., T, J., Z, Z., Y, Z., & J, Y. (2022). CDC6 is a prognostic biomarker and correlated with immune infiltrates in glioma.. Molecular cancer. https://doi.org/10.1186/s12943-022-01623-8

Source records

pubmed · retrieved 2026-09-27T01:34:15.023Z